Prediction of Potency of Protease Inhibitors Using Free Energy Simulations with Polarizable Quantum Mechanics-Based Ligand Charges and a Hybrid Water Model

被引:69
作者
Das, Debananda [1 ]
Koh, Yasuhiro [2 ,3 ]
Tojo, Yasushi [2 ,3 ]
Ghosh, Arun K. [4 ,5 ]
Mitsuya, Hiroaki [1 ,2 ,3 ]
机构
[1] NCI, Expt Retrovirol Sect, HIV & AIDS Malignancy Branch, NIH, Bethesda, MD 20892 USA
[2] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Dept Hematol, Kumamoto 8608556, Japan
[3] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Dept Infect Dis, Kumamoto 8608556, Japan
[4] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA
[5] Purdue Univ, Dept Med Chem, W Lafayette, IN 47907 USA
基金
美国国家卫生研究院;
关键词
ORALLY BIOAVAILABLE INHIBITOR; RESOLUTION CRYSTAL-STRUCTURES; STRUCTURE-BASED DESIGN; VIRUS TYPE-1 PROTEASE; HIV-1; PROTEASE; DRUG-RESISTANCE; MOLECULAR DOCKING; IN-VITRO; ACTIVE-SITE; BINDING;
D O I
10.1021/ci900320p
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Reliable and robust prediction of the binding affinity for drug molecules continues to be a daunting challenge. We simulated the binding interactions and free energy of binding of nine protease inhibitors (PIS) with wild-type and various mutant proteases by performing GBSA simulations in which each PI's partial charge was determined by quantum mechanics (QM) and the partial charge accounts for the polarization induced by the protease environment. We employed a hybrid solvation model that retains selected explicit water molecules in the protein with surface-generalized Born (SGB) implicit solvent. We examined the correlation of the free energy with the antiviral potency of PIS with regard to amino acid Substitutions in protease. The GBSA free energy thus simulated showed strong correlations (r > 0.75) with antiviral IC50 Values Of PIS when amino acid substitutions were present in the protease active site. We also simulated the binding free energy of PIS with P2-bis-tetrahydrofuranylurethane (bis-THF) or related cores. utilizing a bis-THF-containing protease crystal structure as a template. The free energy showed a strong correlation (r = 0.93) with experimentally determined anti-HIV-1 potency. The present data suggest that the presence of selected explicit water in protein and protein polarization-induced quantum charges for the inhibitor, compared to lack of explicit water and a static force-field-based charge model, can serve as ail improved lead optimization tool and warrants further exploration.
引用
收藏
页码:2851 / 2862
页数:12
相关论文
共 52 条
[1]   A novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI), GRL-98065, is potent against multiple-PI-resistant human immunodeficiency virus in vitro [J].
Amano, Masayuki ;
Koh, Yasuhiro ;
Das, Debananda ;
Li, Jianfeng ;
Leschenko, Sofiya ;
Wang, Yuan-Fang ;
Boross, Peter I. ;
Weber, Irene T. ;
Ghosh, Arun K. ;
Mitsuya, Hiroaki .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (06) :2143-2155
[2]   NEW METHOD FOR PREDICTING BINDING-AFFINITY IN COMPUTER-AIDED DRUG DESIGN [J].
AQVIST, J ;
MEDINA, C ;
SAMUELSSON, JE .
PROTEIN ENGINEERING, 1994, 7 (03) :385-391
[3]   STRUCTURAL BASIS OF DRUG-RESISTANCE FOR THE V82A MUTANT OF HIV-1 PROTEINASE [J].
BALDWIN, ET ;
BHAT, TN ;
LIU, BS ;
PATTABIRAMAN, N ;
ERICKSON, JW .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (03) :244-249
[4]   Free energy simulations of uncatalyzed DNA replication fidelity:: Structure and stability of T•G and dTTP•G terminal DNA mismatches flanked by a single dangling nucleotide [J].
Bren, Urban ;
Martinek, Vaclav ;
Florian, Jan .
JOURNAL OF PHYSICAL CHEMISTRY B, 2006, 110 (21) :10557-10566
[5]   Inherent Stereospecificity in the Reaction of Aflatoxin B1 8,9-Epoxide with Deoxyguanosine and Efficiency of DNA Catalysis [J].
Brown, Kyle L. ;
Bren, Urban ;
Stone, Michael P. ;
Guengerich, F. Peter .
CHEMICAL RESEARCH IN TOXICOLOGY, 2009, 22 (05) :913-917
[6]   Importance of accurate charges in molecular docking: Quantum mechanical/molecular mechanical (QM/MM) approach [J].
Cho, AE ;
Guallar, V ;
Berne, BJ ;
Friesner, R .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2005, 26 (09) :915-931
[7]   What has virtual screening ever done for drug discovery? [J].
Clark, David E. .
EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (08) :841-851
[8]   Analysis of HIV-1CRF_01 A/E protease inhibitor resistance: Structural determinants for maintaining sensitivity and developing resistance to atazanavir [J].
Clemente, JC ;
Coman, RM ;
Thiaville, MM ;
Janka, LK ;
Jeung, JA ;
Nukoolkarn, S ;
Govindasamy, L ;
Agbandje-McKenna, M ;
McKenna, R ;
Leelamanit, W ;
Goodenow, MM ;
Dunn, BM .
BIOCHEMISTRY, 2006, 45 (17) :5468-5477
[9]   Comparing the accumulation of active- and nonactive-site mutations in the HIV-1 protease [J].
Clemente, JC ;
Moose, RE ;
Hemrajani, R ;
Whitford, LRS ;
Govindasamy, L ;
Reutzel, R ;
McKenna, R ;
Agbandje-McKenna, M ;
Goodenow, MM ;
Dunn, BM .
BIOCHEMISTRY, 2004, 43 (38) :12141-12151
[10]   Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 3. The free energy contribution of structural water molecules in HIV-1 protease complexes [J].
Fornabaio, M ;
Spyrakis, F ;
Mozzarelli, A ;
Cozzini, P ;
Abraham, DJ ;
Kellogg, GE .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (18) :4507-4516